Rocket Pharmaceuticals Inc (RCKT) Options

RCKT new 52 week high

How's it up 38% @ $21.00 PPS when diluting $175,000,000 million @ $16.00??

I have been away at hunting camp for a few weeks, and when I got back I was pleasantly surprised. This puppy has doubled! Any thoughts as to how much more upside there is?

* * $RCKT Video Chart 12-09-2020 * *

Link to Video - click here to watch the technical chart video

Check out Seeking Alpha, January 27, article.
Lots of insider buying and Fast Track status.

How you figure a lot power , Gravity takes it down

This got a lot of power!!

This is a new board for this stock. Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic that the Company has designed to lower intraocular pressure (IOP) by restoring the eye's natural pressure control mechanism. The Company developed this molecule to selectively stimulate a particular adenosine subreceptor in the eye with the effect of augmenting the intrinsic function of the eye's trabecular meshwork (TM). Its product pipeline includes trabodenoson monotherapy delivered in an eye drop formulation, as well as a fixed-dose combination (FDC), of trabodenoson with latanoprost given once-daily (QD). The Company is evaluating the potential of trabodenoson to slow the loss of vision associated with glaucoma and degenerative retinal diseases.